A recently published staffing model survey has brought new insights into oncology pharmacy operations across the country.

The Hematology/Oncology Pharmacy Association Practice Outcomes and Professional Benchmarking Committee (POPBC) Oncology Pharmacy Staffing Model Task Force developed a survey-based study in order to help provide an outline of oncology pharmacy staffing and operation practices. Distributed between September 2021 and January 2022, the survey collected baseline data and staffing metrics for oncology pharmacies - including facilities, inpatient and outpatient services, informatics/technology and more. The responses not only provided further insight into the unique oncology pharmacy operations and staffing models around the country, but also highlighted a need for staffing model benchmarking and metrics.

The full results are now published in the Journal of Oncology Pharmacy Practice.


Authors: Andrew Wechter, Anne M. McDonnell, Emily Zimdars, Leanne Sakamoto and Mark Hamm

Read the full article here

Late Breaking News

Clinical Oncology Pharmacy Technician: Impact of a New Role on Pharmacy and Patient Metrics at a Large Academic Cancer Center

A recently published article details the impact of having an inpatient clinical oncology pharmacy technician program.

LED sign that reads CAR T Cells
HOPA News Late Breaking News

Late-Breaking HOPA News: CAR-T Approval Updates

CAR-T approval updates show the treatment moving up the rung in Multiple Myeloma and breaking ground in Chronic Lymphocytic Leukemia

Early-Stage Non-small Cell Lung Cancer
Late Breaking News

Late-Breaking HOPA News: Adjuvant Alectinib in Early-Stage Non-small Cell Lung Cancer (NSCLC)

In April 2024, the FDA approved alectinib (Alecensa®) in patients with early-stage ALK-positive non-small cell lung cancer (NSCLC) based on the ALINA trial.